Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)
A Randomized Phase III Trial of Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Carboplatin in Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)
Sponsor: Haruhiko Fukuda
A PHASE3 clinical study on Uterine Cervical Neoplasms, this trial is completed. The trial is conducted by Haruhiko Fukuda and has accumulated 5 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Feb 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Haruhiko Fukuda
- Ministry of Health, Labour and Welfare, Japan
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Akashi,Kitaouji-cho,13-70, Japan , Bunkyo-ku,Hongo,3-1-3, Japan , Bunkyo-ku,Hongo,7-3-1, Japan , Chuo-ku,Tsukiji,5-1-1, Japan , Fukuoka,Higashi-ku,Maidashi,3-1-1, Japan , Fukuoka,Minami-ku,Notame,3-1-1, Japan , Kagoshima,Kajiya-cho,20-17, Japan , Kawagoe,Komoda,1981, Japan , Kita-adachi,Ina,Komuro,818, Japan , Koto-ku,Ariake,3-10-6, Japan and 20 more locations